Titled “Improving the Safety and Security of Biological Research,” the executive order directs the White House’s Director of the Office of Science and Technology Policy to work with federal agencies to issue guidance that will end federal funding of all gain-of-function research in the U.

U.S. President Donald Trump signed an executive order on Monday that aims to reduce the time it takes to approve pharmaceutical plants in the country, as part of new regulations to encourage domestic manufacturing.

Trump ordered restrictions on gain-of-function research, which involves experimenting with viruses and has the potential to cause pandemics.